Johnson & Johnson vs iShares Silver Trust — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while iShares Silver Trust trades at $53.2. The key difference: Johnson & Johnson pays a 2.15% dividend while iShares Silver Trust pays none, and Johnson & Johnson is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| JNJ | SLV | |
|---|---|---|
Market Cap | $598.96B | — |
Volume | 6,156,228 | — |
Sector | Health | — |
52-Week High | $267.24 | $105.57 |
52-Week Low | $164.36 | $33.32 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →